Patrick W. Weerwind
Research Subjects
Patrick W. Weerwind has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Antoine P. Simons
Department of Cardiothoracic Surgery, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC), Maastricht, Netherlands
2 shared publications Jos G. Maessen
Department of Cardiothoracic Surgery and Cardiovascular Research Institute Maastricht Maastricht The Netherlands
2 shared publicationsSteven Teerenstra
Department of Epidemiology, Biostatistics and Health Technology Assessment Radboud University Nijmegen Medical Centre Nijmegen The Netherlands
2 shared publicationsC.P.M. Reutelingsperger
Department of Biochemistry, Maastricht University, Maastricht - The Netherlands
1 shared publicationD.S. De Jong
Department of Cardiothoracic Surgery / Extracorporeal Circulation, University Hospital Maastricht, Maastricht - The Netherlands
1 shared publicationDennis C. Bergmans
Department of Intensive Care Medicine Maastricht University Medical Centre Maastricht the Netherlands
1 shared publication
Latest Publications
- 18 February 2013
- Published by Wiley in Artificial Organs
- Vol. 37 (3) , 276-282
Hypovolemia in Extracorporeal Life Support Can Lead to Arterial Gaseous Microemboli
Next to severely decreased pump flow, hypovolemia in extracorporeal life support (ELS) can result in subatmospheric venous line pressure. Such pressure may lead to degassing and resultant gaseous microemboli (GME), with potential changes in neurological clinical outcome. CME activity resulting from degassing was investigated in relation to subatmospheric venous line pressure, partial oxygen pressure (pO2 ), and hematocrit in a model of a centrifugal pump-based circuit for long-term ELS. Additionally, a device that provides instantaneous volume buffer capacity during hypovolemia was evaluated in relation to GME appearance. An exponential relationship was found between decreasing venous line pressure and GME downstream of the centrifugal pump (P = 0.001). Arterial bubble activity appeared at subatmospheric venous line pressures of -200 mm Hg and less. A rising (pO2 ) increased formation of GME (P = 0.05). A rise in hematocrit, in contrast, did not affect embolic activity (P = 0.22). With simulated hypovolemia, volume buffer capacity added to the venous line dampened fluctuations of venous line pressure by approximately 40%, but a significant reduction in GME formation could not be found (P = 0.22). Moreover, the device enabled a 14% higher support flow. With ELS flow being related to patient volume status, hypovolemia can diminish support. A coherent decrease of venous line pressure triggers degassing of blood-dissolved gases and causes arterial GME, which can become massive during persistent conditions of limited venous return. Incorporation of a volume buffer capacity device into the extracorporeal support circuit enables a higher and more stable support flow in critically low patient filling.
- 18 February 2013
- Published by Wiley in Artificial Organs
- Vol. 37 (3) , 276-282
Hypovolemia in Extracorporeal Life Support Can Lead to Arterial Gaseous Microemboli
Next to severely decreased pump flow, hypovolemia in extracorporeal life support (ELS) can result in subatmospheric venous line pressure. Such pressure may lead to degassing and resultant gaseous microemboli (GME), with potential changes in neurological clinical outcome. CME activity resulting from degassing was investigated in relation to subatmospheric venous line pressure, partial oxygen pressure (pO2 ), and hematocrit in a model of a centrifugal pump-based circuit for long-term ELS. Additionally, a device that provides instantaneous volume buffer capacity during hypovolemia was evaluated in relation to GME appearance. An exponential relationship was found between decreasing venous line pressure and GME downstream of the centrifugal pump (P = 0.001). Arterial bubble activity appeared at subatmospheric venous line pressures of -200 mm Hg and less. A rising (pO2 ) increased formation of GME (P = 0.05). A rise in hematocrit, in contrast, did not affect embolic activity (P = 0.22). With simulated hypovolemia, volume buffer capacity added to the venous line dampened fluctuations of venous line pressure by approximately 40%, but a significant reduction in GME formation could not be found (P = 0.22). Moreover, the device enabled a 14% higher support flow. With ELS flow being related to patient volume status, hypovolemia can diminish support. A coherent decrease of venous line pressure triggers degassing of blood-dissolved gases and causes arterial GME, which can become massive during persistent conditions of limited venous return. Incorporation of a volume buffer capacity device into the extracorporeal support circuit enables a higher and more stable support flow in critically low patient filling.
- Open Access
- 1 August 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 36 (2) , 330-334
Dynamic filling index: a novel parameter to monitor circulatory filling during minimized extracorporeal bypass
Objective: To evaluate the dynamic filling index, a novel parameter to monitor changes in venous return and drainable volume, in circulatory assisted patients. Minimized extracorporeal bypass systems lack volume buffering capacity, demanding tight control of drainable volume to maintain bypass flow. Therefore, with patients on minimized bypass quantitative assessment of venous drainable volume is crucial. Methods: In seven patients undergoing coronary artery bypass grafting using minimized extracorporeal bypass we utilized luxation of the heart to induce a reduction in venous return. The speed of the centrifugal pump was transiently and periodically reduced to monitor resultant changes in bypass flow. The dynamic filling index, a measure of drainable volume, was calculated as Δflow/Δspeed. Results: With luxation, the dynamic filling index was significantly reduced (from 2.4 ± 0.2 to 2.0 ± 0.2 ml/rotation, p = 0.001; 95% confidence interval of mean difference: 0.23–0.46 ml/rotation), whereas routinely recorded parameters, like bypass flow, pump inlet and arterial line pressure, did not change significantly. The intra-measurement reproducibility for the dynamic filling index was 0.5 ml/rotation (20% of the mean), suggesting good potential for this parameter to monitor on-pump venous return in patients. Conclusion: The dynamic filling index can detect small changes in venous return and drainable volume which remain unrevealed by routinely recorded parameters. This index could be a valuable tool to monitor and control circulatory filling in individual patients supported by minimized extracorporeal bypass.
- 1 August 2009
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 36 (2) , 330-334
Open AccessDynamic filling index: a novel parameter to monitor circulatory filling during minimized extracorporeal bypass
Objective: To evaluate the dynamic filling index, a novel parameter to monitor changes in venous return and drainable volume, in circulatory assisted patients. Minimized extracorporeal bypass systems lack volume buffering capacity, demanding tight control of drainable volume to maintain bypass flow. Therefore, with patients on minimized bypass quantitative assessment of venous drainable volume is crucial. Methods: In seven patients undergoing coronary artery bypass grafting using minimized extracorporeal bypass we utilized luxation of the heart to induce a reduction in venous return. The speed of the centrifugal pump was transiently and periodically reduced to monitor resultant changes in bypass flow. The dynamic filling index, a measure of drainable volume, was calculated as Δflow/Δspeed. Results: With luxation, the dynamic filling index was significantly reduced (from 2.4 ± 0.2 to 2.0 ± 0.2 ml/rotation, p = 0.001; 95% confidence interval of mean difference: 0.23–0.46 ml/rotation), whereas routinely recorded parameters, like bypass flow, pump inlet and arterial line pressure, did not change significantly. The intra-measurement reproducibility for the dynamic filling index was 0.5 ml/rotation (20% of the mean), suggesting good potential for this parameter to monitor on-pump venous return in patients. Conclusion: The dynamic filling index can detect small changes in venous return and drainable volume which remain unrevealed by routinely recorded parameters. This index could be a valuable tool to monitor and control circulatory filling in individual patients supported by minimized extracorporeal bypass.
- 4 November 2006
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 21 (1) , 7-12
Conductivity-Based Hematocrit Measurement During Cardiopulmonary Bypass
In a recent clinical study on the reliability of a point-of-care (POC) analyzer, we described a downward bias in hematocrit measurement during cardiopulmonary bypass leading potentially to overtreatment with packed red cells. We hypothesized that the detected deviation is caused by variations in electrolyte concentration rather than by colloids used. Blood was sampled from patients before cardiac surgery to obtain undiluted anticoagulated whole blood samples (n = 53). From each sample, four dilution series covering a hematocrit range of 15–30% were made using NaCl (0.9%), modified gelatine (4%), hydroxyethylstarch (6%), or a potassium-based (16 mEq/l) solution, respectively. In each dilution series, hematocrit was measured by POC and via the “golden standard” microcentrifugal method to determine whether the deviation of the POC-analyzer to the microcentrifuge was dependent on the type and dilution level of the solution used. In contrast to the colloid-based dilution series, the crystalloids revealed a significant downward bias of the POC-analyzer with respect to the microcentrifuge (p < 0.05). Due to the correction algorithm for sodium in the POC-analyzer, this deviation was nearly constant for NaCl (mean of difference: −1.8 ± 0.1%), but increased significantly in case of the potassium-based solution (up to −8.2 ± 0.4% after 1.5-times dilution). The starch- and gelatine-based solutions led to a significant upward bias (p < 0.05) that increased with progressing dilution (up to 1.2 ± 0.1% for hydroxyethylstarch and up to 1.3 ± 0.1% for modified gelatine after 1.5-times dilution). Conductivity-based POC hematocrit measurement suffers from biases due to changes of the plasma constituents. The downward bias in hematocrit as often seen during cardiopulmonary bypass is driven by changes of different electrolyte concentration rather than by colloids used per se.
- 4 November 2006
- Published by Springer Nature in Journal of Clinical Monitoring and Computing
- Vol. 21 (1) , 7-12
Conductivity-Based Hematocrit Measurement During Cardiopulmonary Bypass
In a recent clinical study on the reliability of a point-of-care (POC) analyzer, we described a downward bias in hematocrit measurement during cardiopulmonary bypass leading potentially to overtreatment with packed red cells. We hypothesized that the detected deviation is caused by variations in electrolyte concentration rather than by colloids used. Blood was sampled from patients before cardiac surgery to obtain undiluted anticoagulated whole blood samples (n = 53). From each sample, four dilution series covering a hematocrit range of 15–30% were made using NaCl (0.9%), modified gelatine (4%), hydroxyethylstarch (6%), or a potassium-based (16 mEq/l) solution, respectively. In each dilution series, hematocrit was measured by POC and via the “golden standard” microcentrifugal method to determine whether the deviation of the POC-analyzer to the microcentrifuge was dependent on the type and dilution level of the solution used. In contrast to the colloid-based dilution series, the crystalloids revealed a significant downward bias of the POC-analyzer with respect to the microcentrifuge (p < 0.05). Due to the correction algorithm for sodium in the POC-analyzer, this deviation was nearly constant for NaCl (mean of difference: −1.8 ± 0.1%), but increased significantly in case of the potassium-based solution (up to −8.2 ± 0.4% after 1.5-times dilution). The starch- and gelatine-based solutions led to a significant upward bias (p < 0.05) that increased with progressing dilution (up to 1.2 ± 0.1% for hydroxyethylstarch and up to 1.3 ± 0.1% for modified gelatine after 1.5-times dilution). Conductivity-based POC hematocrit measurement suffers from biases due to changes of the plasma constituents. The downward bias in hematocrit as often seen during cardiopulmonary bypass is driven by changes of different electrolyte concentration rather than by colloids used per se.
- Open Access
- 1 January 2003
- Published by Springer Nature in Thrombosis Journal
- Vol. 1 (1) , 3
Thrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field
In spite of using heparin-coated extracorporeal circuits, cardiopulmonary bypass (CPB) is still associated with an extensive thrombin generation, which is only partially suppressed by the use of high dosages of heparin. Recent studies have focused on the origins of this thrombotic stimulus and the possible role of retransfused suctioned blood from the thoracic cavities on the activation of the extrinsic coagulation pathway. The present study was designed to find during CPB an association between retransfusion of suctioned blood from the pericardium and pleural space, containing activated factor VIIa and systemic thrombin generation. Blood samples taken from 12 consenting patients who had elective cardiac surgery were assayed for plasma factor VIIa, prothrombin fragment 1+2 (F1+2), and thrombin-antithrombin (TAT) concentrations. Blood aspirated from the pericardium and pleural space was collected separately, assayed for F1+2, TAT, and factor VIIa and retransfused to the patient after the aorta occlusion. After systemic heparinization and during CPB thrombin generation was minimal, as indicated by the lower than base line plasma levels of F1+2, and TAT after correction for hemodilution. In contrast, blood aspirated from the thoracic cavities had significantly higher levels of factor VIIa, F1+2, and TAT compared to the simultaneous samples from the blood circulation (P < 0.05). Furthermore, after retransfusion of the suctioned blood (range, 200–1600 mL) circulating levels of F1+2, and TAT rose significantly from 1.6 to 2.9 nmol/L (P = 0.002) and from 5.1 to 37.5 μg/L (P = 0.01), respectively. The increase in both F1+2, and TAT levels correlated significantly with the amount of retransfused suctioned blood (r = 0.68, P = 0.021 and r = 0.90, P = 0.001, respectively). However, the circulating factor VIIa levels did not correlate with TAT and F1+2 levels. These data suggest that blood aspirated from the thoracic cavities during CPB is highly thrombogenic. Retransfusion of this blood may, therefore, promote further systemic thrombin generation during CPB.
- 1 January 2003
- Published by Springer Nature in Thrombosis Journal
- Vol. 1 (1) , 3
Open AccessThrombin generation during cardiopulmonary bypass: the possible role of retransfusion of blood aspirated from the surgical field
In spite of using heparin-coated extracorporeal circuits, cardiopulmonary bypass (CPB) is still associated with an extensive thrombin generation, which is only partially suppressed by the use of high dosages of heparin. Recent studies have focused on the origins of this thrombotic stimulus and the possible role of retransfused suctioned blood from the thoracic cavities on the activation of the extrinsic coagulation pathway. The present study was designed to find during CPB an association between retransfusion of suctioned blood from the pericardium and pleural space, containing activated factor VIIa and systemic thrombin generation. Blood samples taken from 12 consenting patients who had elective cardiac surgery were assayed for plasma factor VIIa, prothrombin fragment 1+2 (F1+2), and thrombin-antithrombin (TAT) concentrations. Blood aspirated from the pericardium and pleural space was collected separately, assayed for F1+2, TAT, and factor VIIa and retransfused to the patient after the aorta occlusion. After systemic heparinization and during CPB thrombin generation was minimal, as indicated by the lower than base line plasma levels of F1+2, and TAT after correction for hemodilution. In contrast, blood aspirated from the thoracic cavities had significantly higher levels of factor VIIa, F1+2, and TAT compared to the simultaneous samples from the blood circulation (P < 0.05). Furthermore, after retransfusion of the suctioned blood (range, 200–1600 mL) circulating levels of F1+2, and TAT rose significantly from 1.6 to 2.9 nmol/L (P = 0.002) and from 5.1 to 37.5 μg/L (P = 0.01), respectively. The increase in both F1+2, and TAT levels correlated significantly with the amount of retransfused suctioned blood (r = 0.68, P = 0.021 and r = 0.90, P = 0.001, respectively). However, the circulating factor VIIa levels did not correlate with TAT and F1+2 levels. These data suggest that blood aspirated from the thoracic cavities during CPB is highly thrombogenic. Retransfusion of this blood may, therefore, promote further systemic thrombin generation during CPB.
- 1 August 2002
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 25 (8) , 770-776
Exposure of Procoagulant Phospholipids on the Surface of Platelets in Patients Undergoing Cardiopulmonary bypass Using Non-Coated and Heparin-Coated Extracorporeal Circuits
Cardiopulmonary bypass (CPB) is associated with a generalized hemostatic defect, in which platelet dysfunction seems to play a central role. The present study was designed to elucidate whether the potential procoagulant activity of platelets, detected as annexin V binding, was altered during coronary bypass surgery, using non-coated and heparin-coated extracorporeal circuits. Thirty patients undergoing elective coronary artery bypass grafting were prospectively randomized using either a standard untreated extracorporeal circuit (n = 15) or a heparin-treated extracorporeal circuit (n=15). Besides measurement of the procoagulant phospholipid activity, the mediastinal blood loss after surgery, and the blood transfusion requirements were also monitored. CPB induced a decrease in the percentage of activated platelets in whole blood, manifest directly after start of CPB, which was significantly attenuated using a non-treated system. Postoperatively, the percentage of activated platelets recovered in both systems, reaching a point of significance 24 hours after the operation, compared to the values 2 hours after the operation. The differences among the groups for mediastinal blood loss during the first 2 and 24 postoperative hours coincided with the differences in procoagulant phospholipid activity. Furthermore, there was no statistical difference among the groups for blood transfusion requirements. The platelets in both groups showed a significantly lower ability to generate ionomycin-induced procoagulant activity after blood-material interaction when compared to the baseline values. These observations are compatible with the notion that during CPB, irrespective of the heparin coating, platelets become modestly activated.
- 1 August 2002
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 25 (8) , 770-776
Exposure of Procoagulant Phospholipids on the Surface of Platelets in Patients Undergoing Cardiopulmonary bypass Using Non-Coated and Heparin-Coated Extracorporeal Circuits
Cardiopulmonary bypass (CPB) is associated with a generalized hemostatic defect, in which platelet dysfunction seems to play a central role. The present study was designed to elucidate whether the potential procoagulant activity of platelets, detected as annexin V binding, was altered during coronary bypass surgery, using non-coated and heparin-coated extracorporeal circuits. Thirty patients undergoing elective coronary artery bypass grafting were prospectively randomized using either a standard untreated extracorporeal circuit (n = 15) or a heparin-treated extracorporeal circuit (n=15). Besides measurement of the procoagulant phospholipid activity, the mediastinal blood loss after surgery, and the blood transfusion requirements were also monitored. CPB induced a decrease in the percentage of activated platelets in whole blood, manifest directly after start of CPB, which was significantly attenuated using a non-treated system. Postoperatively, the percentage of activated platelets recovered in both systems, reaching a point of significance 24 hours after the operation, compared to the values 2 hours after the operation. The differences among the groups for mediastinal blood loss during the first 2 and 24 postoperative hours coincided with the differences in procoagulant phospholipid activity. Furthermore, there was no statistical difference among the groups for blood transfusion requirements. The platelets in both groups showed a significantly lower ability to generate ionomycin-induced procoagulant activity after blood-material interaction when compared to the baseline values. These observations are compatible with the notion that during CPB, irrespective of the heparin coating, platelets become modestly activated.